Journal
AMERICAN JOURNAL OF AUDIOLOGY
Volume 30, Issue 3S, Pages 887-900Publisher
AMER SPEECH-LANGUAGE-HEARING ASSOC
DOI: 10.1044/2021_AJA-21-00006
Keywords
-
Funding
- National Institute on Deafness and Other Communication Disorders [R01 DC004555, R01 DC016880]
Ask authors/readers for more resources
This review article summarizes the current understanding of acquired hearing loss mechanisms caused by hospital-prescribed medications in Western Europe and North America. It emphasizes the knowledge gaps regarding iatrogenic causes of hearing loss and calls for further research to better prevent and treat drug-induced hearing loss.
Purpose: This review article summarizes our current understanding of the mechanisms underlying acquired hearing loss from hospital-prescribed medications that affects as many as 1 million people each year in Western Europe and North America. Yet, there are currently no federally approved drugs to prevent or treat the debilitating and permanent hearing loss caused by the life-saving platinum-based anticancer drugs or the bactericidal aminoglycoside antibiotics. Hearing loss has long-term impacts on quality-of-life measures, especially in young children and older adults. This review article also highlights some of the current knowledge gaps regarding iatrogenic causes of hearing loss. Conclusion: Further research is urgently needed to further refine clinical practice and better ameliorate iatrogenic drug-induced hearing loss.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available